Sikiric et al., in a 2018 review published in Current Pharmaceutical Design, outlined BPC-157's capacity to upregulate growth factor receptors including VEGFR2 and EGFR, facilitating wound healing, tendon repair, and gastrointestinal mucosal recovery in rodent models
This distinction is exactly why Dr Ritus feature in The Australian warned against GHK copper peptide injections, highlighting that while safe topical treatments offer clinical benefits, unregulated injectables carry severe, unproven risks
Kobayashi A, Iwasaki H
Lyophilized preparations should remain sealed and stored at -20C away from light and moisture
Despite the warning label, individuals continue to use them and the individual does not know what they are getting all the time. There is some research on the following peptide injections: Body Protection Compound-157 (BPC-157) Initial and pre-clinical-trial research suggest BPC-157 may promote musculoskeletal healing, which could explain its popularity among athletes (although it is banned in professional sports)
Not accurately
